Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature
- 1 March 1983
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 143 (3) , 437-441
- https://doi.org/10.1001/archinte.143.3.437
Abstract
Three cases of severe reversible azotemia secondary to captopril therapy in hypertension were observed. All patients had extensive peripheral vascular disease involving the renal arteries, and 2 patients (patients 2 and 3) had high levels of peripheral plasma renin activity. The azotemia occurred approximately 2 wk after exposure to captopril, and fever, a maculopapular pruritic cutaneous rash and eosinophilia developed in 2 patients (patients 2 and 3). The cause of the azotemia in our patients is not clearly known, since renal biopsies were not performed. The most likely cause for the azotemia was volume contraction with reduction in the glomerular filtration rate, although a direct insult to the kidney could not be excluded.This publication has 13 references indexed in Scilit:
- Membranous Glomerulopathy in a Patient on CaptoprilActa Medica Scandinavica, 1980
- IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRILThe Lancet, 1979
- Hemodialysis-Resistant Hypertension: Control with an Orally Active Inhibitor of Angiotensin-Converting Enzyme*Journal of Clinical Endocrinology & Metabolism, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILUREThe Lancet, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Effect of Saralasin in Hypertensive Patients on Chronic HemodialysisAnnals of Internal Medicine, 1978
- Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbitsEuropean Journal of Pharmacology, 1977
- RELEASE OF A PROSTAGLANDIN E-LIKE SUBSTANCE FROM CANINE KIDNEY BY BRADYKININ - COMPARISON WITH ELEDOISINCirculation Research, 1971
- THE DISAPPEARANCE OF BRADYKININ AND ELEDOISIN IN THE CIRCULATION AND VASCULAR BEDS OF THE CATBritish Journal of Pharmacology and Chemotherapy, 1967